Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. finance.yahoo.com › news › bristol-myers-squibbBristol Myers Squibb Presents Multiple New Analyses at 2024 ...

    Hace 17 horas · PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...

  2. Imágenes

    • June Squibb - Rotten Tomatoes
    • June Squibb - IMDb
    • Picture of June Squibb
    • June Squibb - Rotten Tomatoes
    • Actor june squibb
    • June Squibb – Movies, Bio and Lists on MUBI
    • June Squibb

    Ver todo

  3. www.benzinga.com › general › biotechWhy US Drug Giant Bristol Myers Squibb Stock Trading Up On ...

    Hace 17 horas · Bristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12 study evaluating Krazati (adagrasib) compared to standard-of-care chemotherapy for locally advanced ...

  4. de.finance.yahoo.com › news › bristol-myers-squibbBristol Myers Squibb’s Breyanzi Demonstrates Clinically ...

    Hace 17 horas · PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting

  5. Videos

    Ver todo

  6. www.fool.com › investing › 2024/06/032 No-Brainer Dividend Stocks You Can Buy With $100 in June

    Hace 17 horas · Today's Change. (2.26%) $0.93. Current Price. $42.02. Price as of June 3, 2024, 11:22 a.m. ET. This pair of high-yield dividend payers offer yields near 6% and a chance for steady payout raises in ...

  7. www.businesswire.com › portal › siteAll News | Business Wire

    Hace 17 horas · Today is June 03, 2024. All ... Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual ...

  8. www.pharmalive.com › do-karuna-cerevel-dealsDo Karuna, Cerevel deals signal renewed neuropsychiatric ...

    Hace 17 horas · In December, Bristol Myers Squibb acquired Karuna Therapeutics and its investigational schizophrenia drug, KarXT, for $14 billion, and AbbVie picked up Cerevel Therapeutics and its neuropsychiatric pipeline for $8.7 billion. And last month, AbbVie—which has previously been active in the space—inked a potentially $2 billion deal with ...

  9. www.marketscreener.com › quote › stockBristol Myers: presents advances in lung cancer - MarketScreener

    Hace 4 horas · Bristol Myers: presents advances in lung cancer. June 03, 2024 at 08:58 am EDT. At the annual meeting of the American Society of Clinical Oncology (ASCO), Bristol Myers Squibb presented the results of three studies (CheckMate -77T, CheckMate -816 and CheckMate -9LA) using Opdivo (nivolumab) to treat non-small cell lung cancer (NSCLC).